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Abstract
Background: Current international guidelines advocate achieving at least a 30 % reduction in maximum plantar
pressure to reduce the risk of foot ulcers in people with diabetes. However, whether plantar pressures differ in
cases with foot ulcers to controls without ulcers is not clear. The aim of this study was to assess if plantar pressures
were higher in patients with active plantar diabetic foot ulcers (cases) compared to patients with diabetes without
a foot ulcer history (diabetes controls) and people without diabetes or a foot ulcer history (healthy controls).
Methods: Twenty-one cases with diabetic foot ulcers, 69 diabetes controls and 56 healthy controls were recruited
for this case-control study. Plantar pressures at ten sites on both feet and stance phase duration were measured
using a pre-established protocol. Primary outcomes were mean peak plantar pressure, pressure-time integral and
stance phase duration. Non-parametric analyses were used with Holm’s correction to correct for multiple testing.
Binary logistic regression models were used to adjust outcomes for age, sex and body mass index. Median
differences with 95 % confidence intervals and Cohen’s d values (standardised mean difference) were reported for
all significant outcomes.
Results: The majority of ulcers were located on the plantar surface of the hallux and toes. When adjusted for age,
sex and body mass index, the mean peak plantar pressure and pressure-time integral of toes and the mid-foot
were significantly higher in cases compared to diabetes and healthy controls (p < 0.05). The stance phase duration
was also significantly higher in cases compared to both control groups (p < 0.05). The main limitations of the study
were the small number of cases studied and the inability to adjust analyses for multiple factors.
Conclusions: This study shows that plantar pressures are higher in cases with active diabetic foot ulcers despite
having a longer stance phase duration which would be expected to lower plantar pressure. Whether plantar
pressure changes can predict ulcer healing should be the focus of future research. These results highlight the
importance of offloading feet during active ulceration in addition to before ulceration.
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Background
A large number of studies have suggested that plantar
pressures are high in people with diabetic peripheral
neuropathy (DPN) and in people with a history of dia-
betic foot ulcers (DFUs) [1–12]. It has been proposed
that high plantar pressure predispose people with DPN
to develop DFUs [13, 14]. Hence current international
guidelines advocate achieving at least a 30 % reduction
in maximum plantar pressure to reduce the risk of de-
veloping DFUs [13]. While it is accepted that high plan-
tar pressures in people with DPN lead to DFUs and
remain high following DFUs, it is not known if plantar
pressures are elevated at the time of active DFUs [10].
To complicate the matter, the few studies which have in-
vestigated barefoot plantar pressure in people with active
DFUs have major inconsistencies in the populations
studied and reported results [6, 8, 12, 14–16]. Several stud-
ies have investigated heterogeneous cohorts of people either
with a history of DFUs or with an active DFU [6, 12, 16],
whilst another study only investigated male patients [14]. In
addition, some studies have reported plantar pressures in a
limited number of sites [8, 15] or alternatively reported
aggregated plantar pressure from multiple sites [11, 16].
These inconsistent approaches make it difficult to interpret
whether plantar pressures are actually elevated in people
with active plantar DFUs [10, 17–19].
In a recent meta-analysis of observational studies, we
reported that plantar pressures were not significantly dif-
ferent in people with active DFUs compared to controls
with DPN without active DFUs [10]. The result from this
analysis may have been due to a lack of statistical power
to detect a true difference, or due to the fact that plantar
pressures are not significantly different in cases with ac-
tive DFUs compared to controls [10]. This prospective
study investigated a homogenous cohort of people with
active DFUs and assessed a number of plantar pressure
measures recorded at multiple sites on the plantar sur-
face of both feet. We hypothesised that cases with active
DFUs would have higher magnitudes and durations of
plantar pressure compared to controls [8, 10]. Therefore,
the aim of this study was to assess whether plantar pres-
sures were higher in patients with active unilateral plan-
tar DFUs of >3 months duration (cases) compared to
patients without a foot ulcer history (diabetes controls)
and patients without a diabetes or foot ulcer history
(healthy controls).
Methods
Study design and criteria for inclusion
The full protocol for this study is published elsewhere
[20]. Cases with type-2 diabetes mellitus and DFUs
(DFU group), type-2 diabetes controls (DMC group) and
healthy controls (HC group) were recruited for this
case-control study [20]. Exclusion criteria for all groups
included: (1) orthopaedic, musculoskeletal, vestibular,
visual or neurological problems affecting mobility (other
than DPN); (2) previous orthopaedic surgical interven-
tion of the lower limb; (3) diabetes types other than
type-2 diabetes; (4) peripheral arterial disease defined as
an ankle-brachial pressure index (ABPI) of < 0.8 in either
limb or a past history of or diagnosis or treatment of
peripheral arterial disease; (5) planned vascular recon-
structions in the subsequent 12 months; and (6) preg-
nancy [20]. The exclusion criteria were designed to
avoid inclusion of people with problems impacting on
mobility that would likely mask the impact of a plantar
ulcer on gait.
The DFU and DMC groups were recruited from in-
patient wards, outpatient clinics and community health
clinics within the Townsville Hospital and Health Service
District, Queensland, Australia [20]. The HC group were
recruited through community advertising and from staff
at the university where the study took place. All partici-
pants were recruited in the period July 2012 to May 2014.
The study was approved by two human research ethics
committees [20].
Sample size calculation and case-control matching
Utilising previous research in patients with DPN without
foot ulcers [21], we estimated that 28, 112 and 56 partic-
ipants were required in the DFU, the DMC and the HC
groups, respectively. This was determined using a one-
way analysis of variance (ANOVA) with 80 % power, an
overall significance of 0.05 adjusted for multiple tests
(maximum of 8) to detect a 20 % difference in forefoot
plantar pressure, and a ratio of 1 DFU case: 4 DMCs: 2
HCs. We attempted to match the sex and age (to within
5 years) of controls and cases. We selected an age range
of 5 years to make recruitment feasible and as we
deemed this would be sufficient to reduce any impact
that differences in the ages of cases and controls may
have on the outcomes.
Anthropometric and clinical assessments
All anthropometric and clinical measurements were per-
formed according to previously published protocols [20].
The same assessor (MEF) carried out all assessments.
Briefly, height was assessed using a wall mounted tele-
scopic metal stadiometer (Seca model 220, Seca Scales,
Hamburg, Germany). Body weight was measured using
bioelectrical impedance scales (TANITA TBF 521,
TANITA Corporation, Illinois, United States of America).
Body Mass Index (BMI) was calculated by dividing the
participant’s body mass (kg) by the square of the partici-
pant’s height (m). A standardised metal measuring tape
(KDS F10-02, Muratech-KDS Corporation, Osaka, Japan)
was used to assess hip and waist circumference while the
participant stood in a relaxed positon with feet together
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and arms freely hanging to the side. Good-to-excellent
reproducibility (concordance correlation coefficients be-
tween 0.999 [95 % Confidence Interval (CI): (0.999-0.999)]
and 0.998 [95 % CI: (0.995–0.999)]) have been reported
for all measurements [20].
Foot structure and the presence of orthopaedic foot
abnormalities were assessed in all participants by a
trained podiatrist (MEF). Lesser toe deformities, foot ab-
normalities and arch contours of the feet along with
presence and grade of hallux abducto valgus (HAV) de-
formity were assessed [22], utilising a set protocol and
recognised standards of assessment as described previously
[20]. An extensive account of the methodology used to as-
sess ABPIs, the monofilament score, Michigan Neuropathy
Symptom Score (MNSI), Physical Assessment Score and
haematological markers, specifically glycated haemoglobin
A1C) (HbA1C) and estimated glomerular filtration rate
(eGFR) is reported in our published protocol [20].
Assessment of plantar pressure and stance phase
duration
A Footscan® pressure plate (RSScan International, Olen,
Belgium) was used for plantar pressure assessment. This
plate was 2 m in length, 0.4 m in width and contained
16384 sensors, with individual sensor dimensions of
0.0076 m x 0.0051 m. All pressure data were captured at
a rate of 100 Hz. The three step approach to capturing
data was chosen [23]. This method has been previously
validated and involves each participant taking two steps
before landing on the pressure plate [23]. A standard
protocol for collecting dynamic barefoot plantar pres-
sure data was established prior to commencing data col-
lection [19, 20]. We did not use a walkway during gait
and did not adjust stepping preference. Instead stepping
preference was controlled by asking participants to start
walking with the dominant foot throughout and by com-
mencing from the same distance away from the platform.
Participants were given time to familiarise themselves with
the protocol. Briefly, this protocol included using five gait
assessments per participant as reported in previous litera-
ture [24].
Footscan® processing software (version 8.01) was used
to mask each electronic footprint into ten sites. The lo-
cations included the plantar surfaces of the hallux, toes
2–5, metatarsal one, metatarsal two, metatarsal three,
metatarsal four, metatarsal five, the mid-foot, the lateral
rear-foot and the medial rear-foot (see Fig. 1) [19].
Current debate exists as to which plantar pressure meas-
ure is most appropriate for investigating people at risk of
DFUs [24]. Therefore we measured a range of different
plantar pressure outcomes including: mean peak pres-
sure (mpp) in N/cm2 which quantifies the magnitude of
pressure; pressure-time integral (pti) in Ns/cm2 which
quantifies the duration and magnitude of pressure;
maximum sensor pressure (msp) in N/cm2 and the con-
tact area in cm2. The stance-phase duration (length of
time in milliseconds that the feet were in contact with
the platform) during plantar pressure assessment was re-
corded and averaged for the five selected trials for each
participant as a surrogate measure of gait speed [25].
The mpp and pti and stance phase duration were con-
sidered as primary outcome measures. The maximum
sensor pressure and contact area were considered as sec-
ondary outcomes. These measurements were reported by
the software for the left and right foot for each participant
during barefoot gait [20]. We have previously reported the
reproducibility of plantar pressure assessments [19]. Mpp
and pti measurements assessed at most anatomical loca-
tions typically resulted in coefficients of variations (cvs)
below 30 % and were more reproducible than msp mea-
surements [19].
Statistical analysis
SPSS 20.0 for Windows (SPSS Inc., Illinois, United States of
America) was used for statistical analyses. Non-parametric
analyses were selected as the majority of continuous data
were not normally distributed. A p-value of <0.05 was used
throughout as an indicator of statistical significance.
Descriptive statistics were reported by groups for continu-
ous and categorical variables and consisted of sample size,
median and interquartile range [IQR] or numbers and
percentages (%). These were statistically compared be-
tween the three patient groups initially, followed by post
hoc (between two-group) tests. Diabetes related outcomes
(HbA1c, diabetes duration, overall monofilament score,
MSNI scores, eGFR and insulin use) were only compared
between the DFU and DMC groups. We used the
Fig. 1 Example of allocation of masks to plantar sites. Legend:
T1 = toe 1, T2-5 = toes 2 to 5, M1 =metatarsal 1, M2 =metatarsal 2,
M3 =metatarsal 3, M4 =metatarsal 4, M5 =metatarsal 5, MF =mid-foot,
HM =medial heel, HL = lateral heel
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Kruskal-Wallis test and the Mann-Whitney U test or the
Pearson’s chi-square tests. We only used the Fishers exact
test, if expected frequencies were less than or equal to five
for categorical outcomes.
To test our main hypothesis, the plantar pressure data
for the ulcerated foot in cases were compared to the
average plantar pressures from the left and right foot in
the appropriate control group. Initial comparisons of the
primary outcomes (mpp, pti and stance phase duration)
and secondary outcomes (contact area and msp) were
performed using the Kruskal-Wallis test, followed by
post hoc comparisons using the Mann-Whitney U test.
We also carried out paired analyses between the relevant
descriptive factors and outcome measures of the ulcer-
ated and non-ulcerated feet of the DFU group using the
Wilcoxon Signed Rank and McNemar’s tests. As mul-
tiple outcomes were tested in this study, we corrected
the p-values from primary and secondary outcome test
results using the Holm step-wise correction [26]. Stance
phase duration was not corrected. Between two-group
comparisons were reported as estimated differences in
the median (Δ) with 95 % CIs using Hodges-Lehmann
estimates from ranks [27].
Binary logistic regression analyses were used to adjust
all significant post-hoc comparison outcomes for age, sex
and BMI. Odds Ratios (ORs) and 95 % CIs of binary logis-
tic regression results were computed; significant differ-
ences were flagged and reported within Additional file 1.
Only outcome data which was significant after correction
and adjustment were reported in the results section of the
paper and within the main data Tables. All other data
(including secondary outcome data) were reported in
Additional file 1. In addition to estimated differences in
the median, Cohen’s d (standardised mean difference) was
calculated for all variables which remained significant after
adjustment and correction, to assess their effect size using
a revised formula for skewed data: Cohen’s d =median
1-median 2/pooled IQR [28]. Effect-size magnitudes were
used to estimate the degree of difference [29]. The size of
the difference was graded based on Cohen’s d as: <0.10
trivial difference; 0.10–0.20 small difference; 0.20–0.60
medium difference; 0.60–1.20 large difference and ≥1.20 a
very large difference [29].
Results
Participant recruitment and statistical power
From 208 participants that were screened for the study,
146 were recruited. This included 21 in the DFU group,
69 in the DMC group and 56 in the HC group. Due to
difficulty in recruitment, a 1:3:3 matching process re-
placed the originally planned 1:4:2. A post-hoc power
test on this recruited sample suggested a power > 80 %
remained using the assumptions of the other sample
size calculation.
Demographic, clinical and foot characteristics
The demographic and clinical characteristics of the partic-
ipants are displayed in Table 1. The DMC group was older
than the HC group (p < 0.05). The two diabetes groups
had more males, a greater weight and BMI compared to
the HC group (all p < 0.05). The DFU group also had a
longer diabetes duration, more insulin use, lower eGFR
and higher MNSI neuropathy scores than the DMC group
(all p < 0.05). The foot morphological characteristics are
reported in Table 2. No significant difference in foot
characteristics existed between the three groups, except
hammertoe deformity which was more commonly present
in the DFU group compared to the DMC and HC groups
(p < 0.01). There were also no significant difference in
foot characteristics when comparing ulcerated and non-
ulcerated feet within the DFU group (see Table 2). The
plantar ulcer locations of the DFU group were at the
lateral heel (n = 2), mid-foot (n = 3), medial forefoot
(n = 2), central forefoot (n = 1), lateral forefoot (n = 1),
apex of lesser digits (n = 5), and hallux (n = 7).
Primary outcomes
All primary outcome data are reported in Table 3 and in
more detail in Additional file 1. The DFU group had sig-
nificantly higher mpp and pti of the toes 2–5 and mid-foot
sites compared to the DMC and HC groups (all p < 0.05).
The mpp of metatarsal 1 was also significantly higher in
the DFU group compared to the HC group (p < 0.05). The
DFU also had significantly longer stance phase duration
compared to the DMC and HC groups (p < 0.05).
Secondary outcomes
All secondary outcome results and paired analyses re-
sults are reported in Additional file 1: Tables S2, S3, S4,
S5, S6 and S7. The DFU group had higher msp of toes
2–5 and higher contact areas of the mid-foot and meta-
tarsal 1 compared to both the DMC group and the HC
group (p < 0.05). The DFU group had a higher msp of
the mid-foot compared to the DMC group (p < 0.05).
None of the plantar pressure outcomes were statistically
significant between the ulcerated and non-ulcerated feet
after correction in paired analyses (see Additional file 1:
Tables S6 and S7).
Discussion
To the best of our knowledge this is the first prospective
study to have simultaneously examined such an exten-
sive assessment of plantar pressures in a homogenous
group of people with active DFUs [20]. Our primary re-
sults show the mpp (representing magnitudes of plantar
pressure) and the pti (representing the duration and
magnitude of plantar pressure) at toes 2–5 and the mid-
foot were significantly higher in cases with DFUs com-
pared to both control groups. Eight out of twenty-one
Fernando et al. BMC Endocrine Disorders  (2016) 16:51 Page 4 of 10
ulcers in cases occurred at these plantar sites. Secondary
results show the msp at the toes and the contact area of
the mid-foot were also significantly higher in cases with
DFUs compared to both controls. These findings occurred
despite a longer stance phase duration representing slower
gait speed in cases with DFUs. Consistent with our hy-
pothesis, although cases with DFUs walked slower, their
forefoot plantar pressures (especially at toes 2–5) were sig-
nificantly higher compared to controls without DFUs.
The plantar pressure data in our diabetes control
group were similar to that of a previous study that used
the same plantar pressure platform [30]. We chose not
to control gait speed in our participants as it has been
reported that people with diabetes walk more cautiously
than healthy controls [31]. However, previous studies
have identified that gait speed can significantly alter the
distribution and magnitude of plantar pressures [32, 33].
Faster gait speeds (i.e. shorter stance phase durations)
have been shown to increase plantar pressure at the heel,
medial and central forefoot and the toes 2–5 while
decreasing plantar pressure beneath the mid-foot and
lateral forefoot [32, 33]. This has been termed a mediali-
sation of the loading pattern [33]. Conversely, a slower
gait speed, as denoted by the longer stance phase
duration, would be expected to produce higher plantar
pressures beneath the mid-foot and lateral forefoot but
lower plantar pressures at all other sites.
While our finding of elevated mid-foot pti and mpp in
cases is consistent with a slower walking speed, our find-
ing that mpp was elevated beneath toes 2–5 is counter
to this effect. Therefore, despite a longer stance phase,
higher plantar pressures still occur in cases with active
DFUs. In a previous meta-analysis we proposed a
‘guarded gait strategy’ may be used by people with active
DFUs to reduce plantar pressure acting on the ulcerated
foot [10]. Our current findings however are contrary to
the presence of a ‘guarded gait strategy’ which would
have resulted in lower plantar pressure in our cases. Our
findings suggest that a longer stance phase is inadequate
to lower the plantar pressure beneath the ulcerated foot
Table 1 Clinical and demographical characteristics of the study cohort by group
DFU group (n = 21) DMC group (n = 69) HC group (n = 56) P value
Age (years) 66.0 [52.0–72.0] 63.0 [58.0–72.0]b 56.0 [55.0–73.0] P = 0.005
Males [number and %] 15 (71.4 %)b 46 (66.7 %)b 24 (42.9 %) P = 0.011
Ethnicity [number and %]
Caucasian 20 (95.2 %) 65 (94.2 %) 54 (96.4 %) P = 0.660
Australian Aboriginal/Indigenous/Torres-strait Islander 1 (4.8 %) 2 (2.9 %) 2 (3.6 %)
Other - 2 (2.9 %) -
Diabetes duration [years] 17.00 [14.5–20.5] 7.5 [4.0–16.5] - P = 0.008
Height (cm) 175.1 [164.8–179.0] 170.0 [163.0–177.5] 170.0 [164.0–174.3] P = 0.199
Weight (kg) 99.6 [82.3–125.1]b 92.3 [80.1–100.7]b 72.9 [64.1–81.6] P < 0.001
BMI (Body Mass Index) 32.3 [27.0–37.9]b 31.0 [29.0–33.4]b 25.8 [23.0–29.3] P < 0.001
Waist to Hip Ratio 1.0 [0.9–1.1] 0.9 [0.9–1.0] 0.9 [0.9–0.9] P = 0.099
Hba1c (mmol/l) 55.5 [46.7–66.5] 51.0 [44.0–61.0] - P = 0.514
Uses Insulin [number and %] 13 (61.9 %)a 19 (27.5 %) - P < 0.001
Smoking Status [number and %]
Never Smoked 14 (66.7 %) 34 (49.3 %) 26 (46.4 %) P = 0.201
Ex-Smoker 6 (28.6 %) 29 (42.0 %) 29 (51.8 %)
Current Smoker 1 (4.8 %) 6 (8.7 %) 1 (1.8 %)
Overall lowest ABPI 1.1 [0.9–1.2] 1.1 [1.0–1.2] 1.0 [1.0–1.1] P = 0.838
Overall Monofilament Score (out of 20) 5.00 [2.5–14.0]a 20.00 [17.5–20.0] 20.00 [20.0–20.0] P < 0.001
MNSI Symptom Score (DPN) 7.00 [6.0–8.0]a 5.00 [3.0–6.0] - P < 0.001
MNSI Physical Assessment Score (DPN) 6.00 [6.0–8.0]a 2.00 [1.0–3.0] - P < 0.001
eGFR 71.0 [56.2–83.5]a 85.0 [71.0–91.0] - P = 0.044
Data displays median and [IQR] and number and percentages (%). All analyses performed were non-parametric. This involved Pearson’s chi-squared tests for
categorical variables and Kruskal-Wallis test for comparisons between three groups and Man-Whitney U test for between DFU and DMC group comparisons and
for post-hoc testing between two groups. A significance level of p = 0.05 was used throughout. Diabetes duration indicates fractions of years living with type-2
diabetes mellitus. ABPI = ankle brachial pressure index. ABPI values are for ulcerated limbs of the DFU group and the lowest reported in the control groups
(DMC, HC). eGFR = estimated glomerular filtration rate (a marker of renal function). Monofilament score is out of a total of 20, measured at ten sites for each foot.
MNSI scores indicate the total scores from the Michigan Neuropathy Screening Instrument in relation to the neuropathy symptom score and physical assessment
score. a = p <0.05 when compared to the DMC group in post-hoc analysis b=p < 0.05 compared to the HC group in post hoc analysis
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during gait [34]. Many factors such as severity of DPN,
foot deformity, excess weight and altered gait patterns
have all been implicated as potential causes of elevated
plantar pressure in people with DFUs [14, 31].
A study by Stokes et al. (1975) suggested a mechanical
aetiology to DFUs in people with DPN [6]. They re-
ported that plantar DFUs may occur at sites of maximal
load in people with DPN [6]. They also reported that
there was a lateral shift of the maximum pressure on the
forefoot and a decrease in the plantar pressure of the
toes in people with DPN [6]. Conversely, our study dem-
onstrated higher plantar pressures beneath toes 2–5 in
cases with active DFUs. This finding may be due to
several reasons including the use of more modern
equipment with greater sensitivity and greater spatial
resolution in our study, or the differences in the popula-
tions studied. Stokes et al. had a heterogeneous cohort
with only two participants with active DFUs while all
our twenty-one cases had active plantar DFUs.
Several DFUs in our cases were located in the toe re-
gion. A significantly higher proportion of participants in
the DFU group also had a hammer-toe deformity of the
lesser toes. A recent study by Barn and colleagues inves-
tigated predictors of barefoot plantar pressure in people
with DPN with a history of DFUs [35]. Barn and col-
leagues found that the presence of local deformity (such
as toes and foot deformities) were the largest contribut-
ing factors to raised barefoot dynamic plantar pressure
in their population [35]. The presence of hammer-toe
deformity was the largest single contributor towards ele-
vated plantar pressure at the lesser toes [35], consistent
with other research [14, 36]. It is possible that the higher
plantar pressures seen in the cases in our study may
have been associated with the presence of hammer-toe
deformity as it has been previously associated with an
increased risk of ulceration due to mechanical load
placed on toes during gait [37]. Interestingly, no differ-
ences in plantar pressures were observed between the
ulcerated and non-ulcerated feet in paired analyses and
this may have been due the high number of bilateral toe
deformities in our cases. In our study, the severity of
Hallux Abducto Valgus deformity was not different be-
tween groups which align with Barn and colleagues find-
ings that the presence of Hallux Abducto Valgus was not
a predictor of plantar pressure [35]. Additionally, all
other foot characteristics showed no differences between
groups or within cases, suggesting that unlike hammer-
toe deformities, other foot characteristics may have a
lesser effect on plantar pressure [14, 17, 38].
The pti is defined as the area under the peak–pressure–
time curve and has been used to study ulceration because
it incorporates pressure as well as time, both of which are
suggested to be important in DFU formation [15, 39]. In
agreement with the view that reporting the pti in addition
to the mpp may be counterproductive [9, 24, 40], the re-
sults from our study demonstrate that both the pti and
Table 2 Foot characteristics of the study cohort by group
Explanatory measure DFU group (n = 21) DMC group
(n = 69)
HC group
(n = 56)
P value P value for
ulcerated vs.
non-ulcerated
feet of cases
[paired]
Ulcerated feet Non-ulcerated feetb
Pes planus feet type 14 (66.7 %) 12 (60.0 %) 29 (42.0 %) 19 (33.9 %)
Normal arched feet type 4 (19.0 %) 4 (20.0 %) 23 (33.3 %) 20 (35.7 %) 0.146 0.317
Pes cavus feet type 3 (14.3 %) 4 (20.0 %) 17 (24.6 %) 17 (30.4 %)
First MTPJ rom (degrees) 30.0 [25.0–45.0] 33.5 [27.5–45.0]a,b 44.0 [30.0–50.0] 45.0 [35.0–60.0] 0.077 0.404
Ankle Joint rom (restricted dorsiflexion) 17 (81.0 %) 16 (80.0 %) 51 (73.9 %) 33 (58.9 %) 0.281 0.368
Subtalar Joint rom (restricted
inversion/eversion)
2 (9.5 %) 1 (5.0 %) 3 (4.4 %) 2 (3.6 %) 0.885 0.846
Hallux Abducto Valgus deformity*
(No deformity) 14 (66.7 %) 14 (70.0 %) 51 (73.9 %) 30 (53.6 %) 0.132 0.392
(Grade 1) 5 (23.8 %) 4 (20.0 %) 13 (18.8 %) 15 (26.8 %)
(Grade 2) 1 (4.8 %) 1 (5.0 %) 3 (4.3 %) 10 (17.9 %)
(Grade 3) 1 (4.8 %) 1 (5.0 %) 2 (2.9 %) 1 (1.8 %)
Claw toe deformity 6 (28.6 %) 8 (40.0 %) 11 (15.9 %) 15 (26.8 %) 0.252 0.500
Hammer toe deformity 12 (57.1 %)a,b 10 (50.0 %)a,b 16 (23.2 %) 9 (16.1 %) 0.001 0.625
Mallet toe deformity 3 (14.3 %) 5 (25.0 %) 14 (20.3 %) 8 (14.3 %) 0.630 0.500
McNemar’s test was performed to assess paired significances between the ulcerated and non-ulcerated feet of the DFU group for categorical outcome and the
Wilcoxon Signed Rank test was used to assess continuous variables. a=p <0.05 when compared to the DMC group in post-hoc analysis b=p < 0.05 compared to the
HC group in post hoc analysis. *Hallux Abducto Valgus (HAV) deformity grades were based on the Manchester scale [22] as reported in the study protocol [20].
**These outcomes were calculated with a denominator of 20 due to missing data for the non-ulcerated foot of one participant in the case group. rom, range of motion
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Table 3 Plantar pressure characteristics of the primary outcome measures by group
Outcome measure DFU group (n = 21) DMC group (n = 69) HC group (n = 56) Corrected P-value Median difference DFU vs.
DMC [95 % CI of difference]
Median difference DFU vs.
HC [95 % CI of difference]
Cohen’s D
DFU vs. DMC
Cohen’s D
DFU vs. HC
Mean Peak plantar Pressure (mpp) N/cm2
Toes 2–5 3.0 [2.4–5.6]a,b 2.5 [1.9–3.1] 2.1 [1.8–2.7] P = 0.007 -0.8 [-1.5–(-)0.9] -1.0 [-1.9–(-)0.5] 0.21 0.40
Metatarsal 1 5.7 [4.5–8.5]b 5.5 [4.3–6.4] 4.6 [3.8–5.4] P = 0.008 - -1.5 [-2.7–(-)0.5] - 0.36
Mid-foot 3.8 [3.1–6.5]a,b 3.0 [2.5–3.7] 2.2 [1.8–2.9] P < 0.001 -0.9 [-2.0–(-)0.3] -1.7 [-3.0–(-)1.1] 0.32 0.63
Pressure-time integral (pti) Ns/cm2
Toes 2–5 0.9 [0.6–1.4]a,b 0.6 [0.5–0.8] 0.5 [0.3–0.6] P = 0.001 0.3 [0.1–0.6] -0.4 [-0.8–(-)0.2] 0.45 0.60
Mid-foot 1.7 [1.2–2.5]a,b 1.0 [0.8–1.3] 0.6 [0.4–0.9] P = 0.001 0.6 [0.3–1.0] -1.0 [-1.3–(-)-0.7] 0.67 1.07
Stance phase duration (ms)
820 [752–960]a,b 739 [699–788] 703 [669–748] P < 0.001* -84 [-140–(-)34] -115 [-163–(-)66] 0.51 0.75
Data displays median and [IQR] values based on the ulcerated feet of the DFU group compared to the reported maximum values in the DMC and HC groups. Corrected p-values indicate p-values obtained after Holm correction
rounded to 3 decimal places. Average stance phase duration indicates the average time the left and right feet were in contact with the ground in milliseconds (ms) from heel contact to toe-off. *Stance phase duration p-values
were not corrected as this was analysed as an independent variable. All above reported plantar pressure outcome data were significant on post-hoc two-way tests and remained significant after adjusting for age, sex and BMI.
Binary logistic regression analyses were only performed for variables which were significant on the post-hoc test. Cohen’s d was only calculated for variables which were significantly different after adjustment. (-) = not computed
as this was not significantly different. See Additional file 1 for odds ratios and additional data. a=p < 0.05 when compared to the DMC group in post-hoc analysis b=p< 0.05 compared to the HC group in post hoc analysis
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the mpp were significantly higher at toes and at the mid-
foot in cases with DFUs compared to either control group.
Conversely, the effect-sizes of the differences in pti mea-
surements were much larger compared to those of mpp.
This observation is consistent with a recent study in
people with DPN without DFUs that identified pti was sig-
nificantly higher in five out of ten possible regional com-
parisons, as opposed to the mpp, which was significantly
higher only in three out of ten comparisons [41].
Another study reported that the difference in pti
between the metatarsal heads and the hallux was far
greater in people with DFUs compared to controls with-
out DFUs [15]. Bacarin et al. have also previously found
that people with DPN and a history of DFUs have a sig-
nificantly higher pti at the mid-foot after controlling for
gait speed [42]. Currently, what the pti represents in the
context of ulceration is still uncertain [24]. A longitu-
dinal analysis of both the pti and mpp measurements in
a cohort of people with healing and non-healing DFUs
may provide information regarding the importance of
these two parameters on ulcer healing [15, 20]. For ex-
ample, it may be possible that one parameter may be
more predictive of ulcer healing. A longitudinal analysis
will also provide observations regarding the variability of
plantar pressures in cases with DFUs when compared to
controls without DFUs over-time [23].
In contrast to the findings of the current study,
Sauseng et al. found that the maximum plantar pressure
and contact area was higher at plantar metatarsal 1 but
was lower at metatarsal 4, metatarsal 5 and at the mid-
foot in people with DFUs compared to controls [15].
The different findings in the current study may be due
to a number of factors. Firstly, in the current study plan-
tar pressures were examined in 10 locations in both feet
however Sauseng et al. only studied seven locations [15].
Sauseng and co-workers pooled plantar pressure data
from the ulcerated and non-ulcerated feet of cases, deb-
rided plantar callus prior to plantar pressure evaluation,
and did not report gait speed or stance phase duration.
They also studied a group of patients with very few
DFUs occurring at toes 2–5 as a majority of the DFUs
were located on the plantar surfaces of the metatarsals
in their study [15]. Nevertheless, the results from Sau-
seng and co-workers are in alignment with our results in
indicating that ulcer location is an important predictor
of the site of high plantar pressure and that higher plan-
tar pressure may occur at ulcer sites in people with
DFUs. Interestingly, Sauseng and co-workers found that
the mpp at the hallux was not higher in people with
DFUs compared to controls, despite the fact that some
DFUs occurred at the hallux, which was also the case in
our study [15]. We were unable to show any difference
in the range of motion of the first metatarsophalangeal
joint between groups in our study. The reason why we
were unable to see higher plantar pressures at the hallux
in people with DFUs may be due to the fact that they were
able to limit the amount of loading on the hallux using
the available range of motion at the first metatarsophalan-
geal joint. This is consistent with our finding of higher
mpp at this site in our cases compared to healthy controls.
Plantar pressures are theoretically the result of the ver-
tical force exerted on the foot during gait divided by the
contact area. Therefore, assuming that the spatial reso-
lution of the sensors were adequate and the plantar skin
surface was completely in contact with the pressure plat-
form during measurement [17], either vertical ground
reaction force has to increase, or the total contact area
for a given site has to decrease in order for plantar pres-
sure to be elevated. We have demonstrated increased
plantar pressures and larger contact areas in cases with
DFUs. These results highlight that vertical ground reac-
tion forces are also likely to be significantly elevated in
cases with DFUs. This is consistent with recent findings
in the same cohort [43]. To our knowledge, although it
is often speculated, increased ground reaction forces
have not been previously reported in people with active
DFUs until recently [43]. These findings suggest that
people with active DFUs experience significantly higher
mechanical stresses during gait. On the other hand,
while plantar pressures represent only the vertical com-
ponent of the applied tissue stress, shear-forces are also
a crucial consideration in the formation of DFUs [41].
As the same local area under the foot can experience
stresses in opposite directions, investigation of shear
forces in cases with DFUs will provide further informa-
tion regarding tissue stresses [44]. The increased contact
areas observed in our cases at several sites is in agree-
ment with the idea that ground reaction forces other
than the vertical force (i.e. shear forces) may also be im-
portant in DFU formation [41]. This is consistent with
the finding that shear forces in the anterior–posterior
direction during gait in the same cohort of people with
DFUs was significantly higher than in controls [43].
Future studies should focus on assessing shear-pressures,
especially at sites of active ulcers.
Our study has a number of limitations and strengths.
We were unable to adjust all our analyses for multiple
factors such as foot deformities, arch type and neur-
opathy severity due to relatively small group sizes. We
examined barefoot gait rather than shod gait and pur-
posefully did not control gait speed as we wanted to
examine the natural gait characteristics of our partici-
pants. We believe that by imposing minimal constraints,
the observed gait would be consistent with the partici-
pant’s everyday gait pattern. We used stance phase dur-
ation as a surrogate measure of gait speed. We were,
however, unable to focus our investigation on individual
ulcer sites due to a small sample-size and resultant lack
Fernando et al. BMC Endocrine Disorders  (2016) 16:51 Page 8 of 10
of statistical power and this area still requires investiga-
tion. We believe that our findings, however, are consist-
ent with plantar pressures representative of a majority of
cases who had DFUs in the forefoot region. There are
differences in plantar pressure values obtained using dif-
ferent platforms with different resolutions and various
methods of assessment, which is a clear limitation in the
field [45]. Our plantar pressure results seem to be lower
than other values reported in the literature, but are con-
sistent with others using the same platform to assess
participants with diabetes [30]. The strengths of our
study include the use of reproducible methodology to
capture plantar pressure, reporting the reproducibility of
plantar pressure acquisition prior to this study [19] and
the use of a conservative statistical approach.
Conclusions
In summary, this study has demonstrated that plantar pres-
sures are higher in cases with active unilateral diabetic foot
ulcers compared to diabetes and healthy controls without
ulcers. Higher plantar pressures occurred in cases despite a
longer stance phase duration which would be expected to
lower plantar pressures. This highlights the importance of
offloading feet during active ulceration to overcome the
mechanical impact of elevated plantar pressures on ulcer-
ated tissue. Evaluating plantar pressures throughout ulcer
progression may provide further clarity on the relationship
between plantar pressures and the mechanical stresses
experienced by patients with active foot ulcers.
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